Argent Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Argent Advisors, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $22.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$22.6M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 19,954 | $4.9M |
| LLYELI LILLY & Co | 4,357 | $4.0M |
| PFEPFIZER INC | 106,730 | $3.0M |
| MRKMerck & Co., Inc. | 24,758 | $3.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 53,310 | $2.9M |
| AMGNAMGEN INC | 4,684 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 11,495 | $1.6M |
| ABBVAbbVie Inc. | 2,626 | $571K |
| NVSNovartis AG | 1,705 | $260K |
| PMPhilip Morris International Inc | 1,572 | $260K |
| ABTABBOTT LABORATORIES | 1,990 | $204K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 745 | $202K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 20,000 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.